tiprankstipranks
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
Holding KPRX?
Track your performance easily

Kiora Pharmaceuticals (KPRX) Financial Statements

416 Followers

Kiora Pharmaceuticals Financial Overview

Kiora Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.535; its P/E ratio is -6.20; Kiora Pharmaceuticals is scheduled to report earnings on February 28, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue-$ 20.00K$ 16.00M--
Gross Profit-$ 20.00K$ 16.00M--
EBIT$ -3.41M$ -2.22M$ 13.23M$ -2.50M$ -2.61M
EBITDA$ -3.41M$ -2.22M$ 13.24M$ -2.49M$ -2.59M
Net Income Common Stockholders$ -3.41M$ -2.22M$ 13.45M$ -6.29M$ -2.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.04M$ 27.78M$ 31.28M$ 5.40M$ 7.95M
Total Assets$ 38.51M$ 40.81M$ 42.44M$ 15.90M$ 19.88M
Total Debt$ 72.64K$ 82.32K$ 94.30K$ 18.73K$ 39.01K
Net Debt$ -28.96M$ -27.69M$ -31.18M$ -5.38M$ -7.91M
Total Liabilities$ 8.48M$ 7.71M$ 7.54M$ 7.79M$ 6.24M
Stockholders Equity$ 30.03M$ 33.10M$ 34.90M$ 8.10M$ 13.64M
Cash Flow-
Free Cash Flow$ 920.06K$ -3.78M$ 13.62M$ -2.52M$ -1.38M
Operating Cash Flow$ 920.06K$ -3.73M$ 13.62M$ -2.52M$ -1.38M
Investing Cash Flow$ -1.92M$ -21.22M---
Financing Cash Flow-$ 250.52K$ 15.25M-$ 5.94M
Currency in USD

Kiora Pharmaceuticals Earnings and Revenue History

Kiora Pharmaceuticals Debt to Assets

Kiora Pharmaceuticals Cash Flow

Kiora Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis